ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue28,216,00025,638,00022,859,000
Cost of Revenue7,040,0005,833,0004,500,000
Gross Profit21,176,00019,805,00018,359,000
Operating Expenses
Research Development4,982,0004,366,0004,285,000
Selling General and Administrative6,275,0005,855,0006,387,000
Non Recurring327,000200,000150,000
Others---
Total Operating Expenses---
Operating Income or Loss9,592,0009,384,0007,537,000
Income from Continuing Operations
Total Other Income/Expenses Net-861,000-535,000-206,000
Earnings Before Interest and Taxes8,731,0008,849,0007,331,000
Interest Expense1,004,000965,000686,000
Income Before Tax7,727,0007,884,0006,645,000
Income Tax Expense2,418,0001,931,0001,501,000
Minority Interest---
Net Income From Continuing Ops5,309,0005,953,0005,144,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income5,309,0005,953,0005,144,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares5,309,0005,953,0005,144,000